Papillomavirus infection
Drug research and approvals for papillomavirus infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 107 studies of papillomavirus infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 107
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- KDTV001 Injection in Patients With Human Papillomavirus (HPV) Types 16, and/or 18, and/or 52 Associated Cervical…NCT07948083 · Phase 1 / Phase 2 · Wuhan KadGeno Biotechnology Co., Ltd · starts Jan 6, 2026
- APL-1702 Photodynamic Therapy in Patients With High-Risk HPV-Positive Cervical Intraepithelial Neoplasia Grade II/III…NCT07944547 · Not applicable · Xiangya Hospital of Central South University · starts May 26, 2025
- Safety, Tolerability, and Efficacy of a Therapeutic Intervention for HPV16/18 InfectionNCT07945119 · Not applicable · Beijing Xunsheng Biomedical Research Co., Ltd. · starts Oct 21, 2025
- AVL-102 for the Treatment of HPV 16/18/52/58-Related High-Grade LesionsNCT07942779 · Phase 1 · Beijing Xunsheng Biomedical Research Co., Ltd. · starts Sep 23, 2026
- C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVNCT07925307 · Not applicable · University of California, San Diego · starts Oct 16, 2026
- Lived Experiences of Women Diagnosed With HPV InfectionNCT07920666 · Not reported · Bilecik Seyh Edebali Universitesi · starts Sep 1, 2026
- Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV DetectionNCT07850128 · Not reported · Karolinska Institutet · starts Oct 31, 2025
- A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine…NCT07785843 · Phase 3 · Merck Sharp & Dohme LLC · starts Oct 10, 2026
- Comparative Self-collection for Cervical Cancer Screening Pivotal StudyNCT07758140 · Not applicable · Mel Mont Medical · starts Jul 9, 2026
How its trials ended
433 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 69 whose ending is known, 59% met their primary endpoint, 6% missed it and 35% stopped early.
- Completed, result not reported16538%
- Ongoing14834%
- Status unknown5112%
- Met its primary endpoint419%
- Stopped: other or unclear153%
- Missed its primary endpoint41%
- Stopped: sponsor or business decision31%
- Stopped: lack of efficacy2<1%
- Stopped: safety2<1%
- Stopped: enrollment or feasibility1<1%
- Stopped: funding1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA